6,070 reports of this reaction
2.2% of all CORTISONE ACETATE reports
#1 most reported adverse reaction
SYSTEMIC LUPUS ERYTHEMATOSUS is the #1 most commonly reported adverse reaction for CORTISONE ACETATE, manufactured by Boiron. There are 6,070 FDA adverse event reports linking CORTISONE ACETATE to SYSTEMIC LUPUS ERYTHEMATOSUS. This represents approximately 2.2% of all 272,029 adverse event reports for this drug.
Patients taking CORTISONE ACETATE who experience systemic lupus erythematosus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SYSTEMIC LUPUS ERYTHEMATOSUS is a less commonly reported adverse event for CORTISONE ACETATE, but still significant enough to appear in the safety profile.
In addition to systemic lupus erythematosus, the following adverse reactions have been reported for CORTISONE ACETATE:
The following drugs have also been linked to systemic lupus erythematosus in FDA adverse event reports:
SYSTEMIC LUPUS ERYTHEMATOSUS has been reported as an adverse event in 6,070 FDA reports for CORTISONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SYSTEMIC LUPUS ERYTHEMATOSUS accounts for approximately 2.2% of all adverse event reports for CORTISONE ACETATE, making it one of the most commonly reported side effect.
If you experience systemic lupus erythematosus while taking CORTISONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.